Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Group 1 - Adagene Inc. Sponsored ADR (ADAG) is currently outperforming its peers in the Medical sector with a year-to-date return of 52.7%, compared to the sector average of 11.9% [2][3] - The Zacks Rank for Adagene Inc. is 2 (Buy), indicating a positive earnings outlook and improving analyst sentiment, with a 24.4% increase in the consensus estimate for full-year earnings over the past quarter [2][3] - Adagene Inc. is part of the Medical - Biomedical and Genetics industry, which includes 497 companies and is currently ranked 81 in the Zacks Industry Rank, showing better performance than the industry average gain of 3% this year [3] Group 2 - DaVita HealthCare (DVA) has also shown strong performance, with a year-to-date return of 47% and a Zacks Rank of 2 (Buy) [2][3] - The consensus EPS estimate for DaVita HealthCare has increased by 3.8% over the past three months, reflecting a positive trend in earnings expectations [3] - DaVita HealthCare belongs to the Medical - Outpatient and Home Healthcare industry, which is ranked 60 and has gained 16.4% so far this year [3]